Search for author "Hani Jneid"

52 Results

Search Term

Type a term to search within all articles in this journal: e.g., stem cell

Content Type

Journals

Figures (Journals Only)

Select types of content to include in the results.

Citation

Citation-specific search information

Year

e.g., 2009

Volume

e.g., 20

Issue

e.g., 3

First page

e.g., 29

DOI

e.g., 10.9999/123XYZ456

ISBN

Limit Results

Limit search results by date

Include articles in Journal:

Include articles in collection:

Include articles in Table of Contents section:

Include articles in Series

Include Only:

Open Access Articles

Review Articles

Exclude meeting abstracts

Format Results

Number of results per page

Sort

Best Match

Oldest First

Newest First

Format Results

Standard Format

Condensed Format

You have access
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Rick A. Nishimura, Catherine M. Otto, Robert O. Bonow, Blase A. Carabello, John P. Erwin, Lee A. Fleisher, Hani Jneid, Michael J. Mack, Christopher J. McLeod, Patrick T. O’Gara, Vera H. Rigolin, Thoralf M. Sundt, Annemarie Thompson

Circulation June 2017, 135 (25) e1159-e1195; DOI: https://doi.org/10.1161/CIR.0000000000000503

Figure 2.
By Rick A. Nishimura, Catherine M. Otto, Robert O. Bonow, Blase A. Carabello, John P. Erwin, Lee A. Fleisher, Hani Jneid, Michael J. Mack, Christopher J. McLeod, Patrick T. O’Gara, Vera H. Rigolin, Thoralf M. Sundt and Annemarie Thompson

Indications for Surgery for MR (Updated Figure 4 From the 2014 VHD guideline). *MV repair is preferred over MV replacement when possible. AF indicates...Show More

Indications for Surgery for MR (Updated Figure 4 From the 2014 VHD guideline). *MV repair is preferred over MV replacement when possible. AF indicates atrial fibrillation; CAD, coronary artery disease; CRT, cardiac resynchronization therapy; EF, ejection fraction; ERO, effective regurgitant orifice; HF, heart failure; LV, left ventricular; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic diameter; MR, mitral regurgitation; MV, mitral valve; NYHA, New York Heart Association; PASP, pulmonary artery systolic pressure; RF, regurgitant fraction; RVol, regurgitant volume; and Rx, therapy.Show Less
You have access
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Rick A. Nishimura, Catherine M. Otto, Robert O. Bonow, Blase A. Carabello, John P. Erwin, Lee A. Fleisher, Hani Jneid, Michael J. Mack, Christopher J. McLeod, Patrick T. O’Gara, Vera H. Rigolin, Thoralf M. Sundt, Annemarie Thompson

Circulation June 2017, 135 (25) e1159-e1195; DOI: https://doi.org/10.1161/CIR.0000000000000503

Figure 1.
By Rick A. Nishimura, Catherine M. Otto, Robert O. Bonow, Blase A. Carabello, John P. Erwin, Lee A. Fleisher, Hani Jneid, Michael J. Mack, Christopher J. McLeod, Patrick T. O’Gara, Vera H. Rigolin, Thoralf M. Sundt and Annemarie Thompson

Choice of TAVR Versus Surgical AVR in the Patient With Severe Symptomatic AS. AS indicates aortic stenosis; AVR, aortic valve replacement; and TAVR, t...Show More

Choice of TAVR Versus Surgical AVR in the Patient With Severe Symptomatic AS. AS indicates aortic stenosis; AVR, aortic valve replacement; and TAVR, transcatheter aortic valve replacement.Show Less
Open Access
Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry
Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson, Hani Jneid

Journal of the American Heart Association October 2016, 5 (10) e004113; DOI: https://doi.org/10.1161/JAHA.116.004113

Figure 1.
By Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson and Hani Jneid

Study cohort development and exclusions. STEMI indicates ST elevation myocardial infarction.Show More

Study cohort development and exclusions. STEMI indicates ST elevation myocardial infarction.Show Less
Open Access
Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry
Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson, Hani Jneid

Journal of the American Heart Association October 2016, 5 (10) e004113; DOI: https://doi.org/10.1161/JAHA.116.004113

View table
Table 1.
By Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson and Hani Jneid

Baseline Characteristics of Patients With STEMI Receiving Fibrinolysis v...
Show More

Baseline Characteristics of Patients With STEMI Receiving Fibrinolysis vs PPCI
Show Less
Open Access
Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry
Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson, Hani Jneid

Journal of the American Heart Association October 2016, 5 (10) e004113; DOI: https://doi.org/10.1161/JAHA.116.004113

Figure 2.
By Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson and Hani Jneid

A, Annual trends in fibrinolysis and PPCI for patients with STEMI in the GWTG‐CAD database. The frequency of...
Show More

A, Annual trends in fibrinolysis and PPCI for patients with STEMI in the GWTG‐CAD database. The frequency of fibrinolysis decreased from 20.5% in 2003 to 3.7% in 2008 while PPCI increased from 79.5% in 2003 to 96.3% in 2008 (P value from Cochran‐Armitage test <0.0001). B, Annual trends in the proportion of patients receiving timely reperfusion with fibrinolysis (DTN ≤30 minutes) and PPCI (DTB ≤90 minutes) for patients with STEMI in the GWTG‐CAD database. The frequency of timely fibrinolysis peaked at 45.8% in 2006 and decreased to 22.9% in 2008 while timely PPCI increased from 37.0% in 2003 to 76.3% in 2008. (P value from Cochran‐Armitage test=0.2769 for DTN ≤30 minutes; P<0.0001 for DTB ≤90 minutes.) C, Annual trends of in‐hospital mortality for patients receiving fibrinolysis and PPCI. In‐hospital mortality was 4.6% in patients receiving fibrinolysis and 3.3% in patients receiving PPCI and did not change significantly over time. (P value from Cochran‐Armitage test=0.9473 for fibrinolytics patients, P=0.1474 for PPCI patients.) CAD indicates coronary artery disease; DTB, door to balloon; DTN, door to needle; GWTG, Get With the Guidelines; PPCI, primary percutaneous coronary intervention; STEMI, ST elevation myocardial infarction.
Show Less
Open Access
Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry
Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson, Hani Jneid

Journal of the American Heart Association October 2016, 5 (10) e004113; DOI: https://doi.org/10.1161/JAHA.116.004113

View table
Table 2.
By Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson and Hani Jneid

In‐Hospital Outcomes Between Patients With STEMI Receiving Fibrinolysis...
Show More

In‐Hospital Outcomes Between Patients With STEMI Receiving Fibrinolysis vs PPCI
Show Less
Open Access
Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry
Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson, Hani Jneid

Journal of the American Heart Association October 2016, 5 (10) e004113; DOI: https://doi.org/10.1161/JAHA.116.004113

View table
Table 3.
By Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson and Hani Jneid

Adherence to CAD Performance Measures Between Patients With STEMI Receiv...
Show More

Adherence to CAD Performance Measures Between Patients With STEMI Receiving Fibrinolysis vs PPCI
Show Less
Open Access
Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry
Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson, Hani Jneid

Journal of the American Heart Association October 2016, 5 (10) e004113; DOI: https://doi.org/10.1161/JAHA.116.004113

View table
Table 4.
By Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson and Hani Jneid

Association of Outcomes With Therapy Type and Timely Reperfusion...
Show More

Association of Outcomes With Therapy Type and Timely Reperfusion
Show Less
Open Access
Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry
Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson, Hani Jneid

Journal of the American Heart Association October 2016, 5 (10) e004113; DOI: https://doi.org/10.1161/JAHA.116.004113

By Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Biykem Bozkurt, Laura A. Petersen, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, Li Liang, Roland A. Matsouaka, Eric D. Peterson and Hani Jneid

Show More

Show Less
You have access
2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures
WRITING COMMITTEE MEMBERS, Joseph P. Drozda, T. Bruce Ferguson, Hani Jneid, Harlan M. Krumholz, Brahmajee K. Nallamothu, Jeffrey W. Olin, Henry H. Ting, ACC/AHA TASK FORCE ON PERFORMANCE MEASURES, Paul A. Heidenreich, Nancy M. Albert, Paul S. Chan, Lesley H. Curtis, T. Bruce Ferguson, Gregg C. Fonarow, P. Michael Ho, Sean O’Brien, Andrea M. Russo, Randal J. Thomas, Henry H. Ting, Paul D. Varosy

Circulation: Cardiovascular Quality and Outcomes January 2016, 9 (1) 68-95; DOI: https://doi.org/10.1161/HCQ.0000000000000014

View table
Table 1.
By WRITING COMMITTEE MEMBERS, Joseph P. Drozda, T. Bruce Ferguson, Hani Jneid, Harlan M. Krumholz, Brahmajee K. Nallamothu, Jeffrey W. Olin, Henry H. Ting, ACC/AHA TASK FORCE ON PERFORMANCE MEASURES, Paul A. Heidenreich, Nancy M. Albert, Paul S. Chan, Lesley H. Curtis, T. Bruce Ferguson, Gregg C. Fonarow, P. Michael Ho, Sean O’Brien, Andrea M. Russo, Randal J. Thomas, Henry H. Ting and Paul D. Varosy

ACC/AHA Secondary Prevention Lipid PMs to Be UpdatedShow More

ACC/AHA Secondary Prevention Lipid PMs to Be UpdatedShow Less

Header Publisher Menu

Circulation

Search for author "Hani Jneid"

52 Results

Pages

Selected Facets

Selected Facets

Publication Date

Publication date

Journal

Source

Article Type

Article Type

Subject

Subject

Customer Service

About Us

Our Sites

Take Action

Online Communities